Frontlight ResearchEarly access
Psoriasis trials, also abroad
278 open Psoriasis trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.
The same trial often runs in several countries
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK) has 8 sites in United Kingdom and runs in 25 countries. If a site near you is full, another one may still take people.
See Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK) in all 25 countries